There are 412 resources available
141P - The causes and consequences of incomplete paclitaxel administration during the neoadjuvant treatment of early triple-negative and HER2 positive breast cancer (CIPNETH)
Presenter: Cedric Van Marcke de Lummen
Session: Lunch and Poster Display session
142P - Exploring 18F-FDG PET as a predictior of immune-related adverse events (irAEs) in early-stage triple-negative breast cancer (eTNBC)
Presenter: Alessia Lucia Daverio
Session: Lunch and Poster Display session
143P - Sociodemographic factors associated with adjuvant chemotherapy receipt in stage I triple-negative breast cancer (TNBC)
Presenter: Candice Thompson
Session: Lunch and Poster Display session
144P - Factors affecting long term outcomes in patients with pathologic complete response after neoadjuvant chemotherapy for early breast cancer: A population-based study
Presenter: Caroline Boman
Session: Lunch and Poster Display session
145P - Impact of immunotherapy addition to dose density of neoadjuvant chemotherapy for triple-negative breast cancer: A retrospective, real-world study from multiple centres in London (UK)
Presenter: Mesel Veli
Session: Lunch and Poster Display session
146P - Long-term outcomes of patients with triple-negative breast cancer treated with adjuvant dose-dense sequential chemotherapy (ddsc): A Hellenic Cooperative Oncology Group (HeCOG) study
Presenter: Elena Fountzilas
Session: Lunch and Poster Display session
147P - Racial bias in pretreatment MRI radiomics features to predict response to neoadjuvant systemic treatment in breast cancer: A multicenter study in China, Germany, and the US
Presenter: Lie Cai
Session: Lunch and Poster Display session
148P - The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy
Presenter: Roberto Buonaiuto
Session: Lunch and Poster Display session
149P - Risk of type II diabetes after breast cancer treatment: A 26-year population-based cohort study
Presenter: Kasper Kjærgaard
Session: Lunch and Poster Display session
150P - Diagnostic accuracy of MRI in tumour response evaluation after neoadjuvant chemotherapy in patients with different subtypes of breast cancer
Presenter: Lucia Vanovcanova
Session: Lunch and Poster Display session